DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,244 filers reported holding DANAHER CORPORATION in Q2 2018. The put-call ratio across all filers is 0.63 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $29,260,434 | +15.2% | 117,112 | +15.1% | 0.07% | +15.9% |
Q1 2024 | $25,397,523 | +16.1% | 101,704 | +7.6% | 0.06% | +5.0% |
Q4 2023 | $21,874,122 | -20.2% | 94,554 | -14.4% | 0.06% | -29.4% |
Q3 2023 | $27,397,435 | -16.4% | 110,429 | -19.2% | 0.08% | -15.8% |
Q2 2023 | $32,786,640 | -78.1% | 136,611 | -77.0% | 0.10% | -81.0% |
Q1 2023 | $149,569,609 | +72.4% | 593,436 | +81.6% | 0.53% | +71.1% |
Q4 2022 | $86,756,509 | +190.5% | 326,865 | +182.7% | 0.31% | +123.7% |
Q3 2022 | $29,865,000 | +20.6% | 115,624 | +18.4% | 0.14% | +32.4% |
Q2 2022 | $24,758,000 | -67.6% | 97,657 | -62.5% | 0.10% | -60.5% |
Q1 2022 | $76,384,000 | +26.2% | 260,401 | +41.5% | 0.27% | +36.4% |
Q4 2021 | $60,537,000 | +39.3% | 183,994 | +28.9% | 0.20% | +28.3% |
Q3 2021 | $43,470,000 | +41.9% | 142,788 | +25.1% | 0.15% | +40.7% |
Q2 2021 | $30,640,000 | +100.9% | 114,168 | +68.5% | 0.11% | +61.2% |
Q1 2021 | $15,255,000 | +97.0% | 67,774 | +94.5% | 0.07% | +97.1% |
Q4 2020 | $7,742,000 | -51.1% | 34,853 | -52.6% | 0.03% | -45.2% |
Q3 2020 | $15,838,000 | +184.1% | 73,552 | +133.3% | 0.06% | +121.4% |
Q2 2020 | $5,575,000 | +158.7% | 31,523 | +102.5% | 0.03% | +100.0% |
Q1 2020 | $2,155,000 | -49.4% | 15,570 | -43.9% | 0.01% | 0.0% |
Q4 2019 | $4,262,000 | -77.9% | 27,764 | -79.2% | 0.01% | -80.6% |
Q3 2019 | $19,283,000 | +37.4% | 133,517 | +36.0% | 0.07% | +41.2% |
Q2 2019 | $14,033,000 | -40.0% | 98,193 | -44.6% | 0.05% | -42.7% |
Q1 2019 | $23,384,000 | +83.7% | 177,122 | +43.5% | 0.09% | +56.1% |
Q4 2018 | $12,729,000 | -83.2% | 123,433 | -82.3% | 0.06% | -79.3% |
Q3 2018 | $75,605,000 | +36.1% | 695,793 | +23.6% | 0.28% | +20.5% |
Q2 2018 | $55,556,000 | +190.6% | 562,992 | +188.4% | 0.23% | +163.2% |
Q1 2018 | $19,115,000 | – | 195,225 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |